Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW 11,160
+150 (1.36%)
Feb 20, 2026, 3:30 PM KST
Whan In Pharm Market Cap
Whan In Pharm has a market cap or net worth of 170.38 billion as of February 20, 2026. Its market cap has decreased by -6.61% in one year.
Market Cap
170.38B
Enterprise Value
111.45B
Revenue
256.32B
Ranking
n/a
PE Ratio
11.40
Stock Price
11,160.00
Market Cap Chart
Since June 24, 1997, Whan In Pharm's market cap has increased from 51.22B to 170.38B, an increase of 232.65%. That is a compound annual growth rate of 4.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 170.38B | -1.41% |
| Dec 30, 2025 | 172.82B | -4.15% |
| Dec 30, 2024 | 180.30B | -21.48% |
| Dec 28, 2023 | 229.62B | -14.55% |
| Dec 29, 2022 | 268.70B | -1.12% |
| Dec 30, 2021 | 271.75B | 6.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jeil Pharmaceutical Co.,Ltd | 215.66B |
| REYON Pharmaceutical | 210.19B |
| JW Lifescience | 205.02B |
| SAMSUNG PHARM. Co., LTD. | 200.01B |
| Hana Pharm | 196.57B |
| Daihan Pharmaceutical | 175.52B |
| Dongwha Pharm.Co.,Ltd | 171.57B |
| Ilsung Is | 168.65B |